Bio-Reference Laboratories (BRLI) Revenue Up 27%

Bio-Reference Laboratories Inc BRLI released financial results on Thursday morning that beat Wall Street estimates. Bio-Reference Laboratories Inc reported that its fiscal 2nd quarter net income rose to $5.8 million, or 21 cents per share, up from $4.6 million, or 17 cents per share, a year earlier. Revenue climbed 27% to $110.4 million, up from $87.2 million a year earlier. According to a poll of analysts by Thomson Reuters, the average Wall Street estimate called for earnings of 19 cents per share.